| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/21/2013 | US8445683 Porphyrin compounds comprising one or more pyridone moieties |
| 05/21/2013 | CA2594264C 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders |
| 05/21/2013 | CA2573223C Aromatic compound |
| 05/21/2013 | CA2560162C Inhibitors of iap |
| 05/21/2013 | CA2396688C Glycosidase inhibitors and methods of synthesizing same |
| 05/16/2013 | WO2013071203A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | WO2013070961A1 Modulators of atp-binding cassette transporters |
| 05/16/2013 | WO2013070887A1 Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections |
| 05/16/2013 | WO2013069615A1 Method for producing 4-benzyl-1-methyl-6-oxabicyclo[3,2,0]heptane derivative |
| 05/16/2013 | WO2013069614A1 Method for producing 4-benzyl-1-methyl-6-oxabicyclo[3,2,0]heptane derivative and method for producing azole derivative |
| 05/16/2013 | WO2013069242A1 Material for organic electroluminescent elements, and organic electroluminescent element using same |
| 05/16/2013 | WO2013068875A1 2-thiopyrimidinones |
| 05/16/2013 | WO2013067669A1 Method for preparing zidovudine and intermediate thereof |
| 05/16/2013 | WO2013067666A1 Method for preparing zidovudine and intermediate thereof |
| 05/16/2013 | WO2012054721A8 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors |
| 05/16/2013 | US20130123508 Novel nonlinear chromophores especially suited for use in electro-optical modulation |
| 05/16/2013 | US20130123507 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 05/16/2013 | US20130123497 Polymorphic forms of lapatinib ditosylate and processes for their preparation |
| 05/16/2013 | US20130123493 Process for the synthesis of substituted urea compounds |
| 05/16/2013 | US20130123305 Fungicide hydroximoyl-tetrazole derivatives |
| 05/16/2013 | US20130123281 Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated Molecules |
| 05/16/2013 | US20130123269 Novel heterocycle compounds and uses thereof |
| 05/16/2013 | US20130123260 Methods |
| 05/16/2013 | US20130123259 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-ones and derivatives thereof as kinase inhibitors |
| 05/16/2013 | US20130123257 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 05/16/2013 | US20130123253 Modulators of central nervous system neurotransmitters |
| 05/16/2013 | US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| 05/16/2013 | US20130123241 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
| 05/16/2013 | US20130123234 Aryl- or Heteroaryl-Substituted Benzene Compounds |
| 05/16/2013 | US20130123230 2-Thiopyrimidinones |
| 05/16/2013 | US20130123215 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | US20130121957 Hepatitis C Virus Inhibitors |
| 05/16/2013 | CA2855390A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | CA2853024A1 2-thiopyrimidinones |
| 05/16/2013 | CA2852991A1 Modulators of atp-binding cassette transporters |
| 05/15/2013 | EP2592905A1 Compound, charge transporting material and organic electroluminescent element |
| 05/15/2013 | EP2592070A2 Tetrazole-substituted arylamides |
| 05/15/2013 | EP2590967A2 Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics |
| 05/15/2013 | EP2590963A1 (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 05/15/2013 | EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 05/15/2013 | EP2590944A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 05/15/2013 | CN103108863A Production of atorvastatin low in ether impurities |
| 05/15/2013 | CN103102346A Phenyl ketone enol compound and application of phenyl ketone enol compound serving as pesticide |
| 05/15/2013 | CN103102231A Chiral multi-substituted 4-hydroxy piperidine compound, and preparation method and application thereof |
| 05/15/2013 | CN102076671B Triazole derivative or salt thereof |
| 05/15/2013 | CN101735205B Crystalline form V of azimilide dihydrochloride, preparation method and application thereof |
| 05/14/2013 | US8440832 Heterocyclic modulators of cannabinoid receptors |
| 05/14/2013 | CA2716369C Phenoxypropylamine compounds |
| 05/14/2013 | CA2631532C Fungicidal composition containing carboxylic acid amide derivative |
| 05/14/2013 | CA2583333C Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/14/2013 | CA2557433C Quinazoline derivatives and therapeutic use thereof |
| 05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/14/2013 | CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 05/10/2013 | WO2013067423A1 Pak inhibitors for the treatment of cell proliferative disorders |
| 05/10/2013 | WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine |
| 05/10/2013 | WO2013067264A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013066078A1 Isocyanurate epoxy compound having alkoxysilyl group, method of preparing same, composition including same, cured product of the composition, and use of the composition |
| 05/10/2013 | WO2013065835A1 Pharmaceutical composition for treating diabetes |
| 05/10/2013 | WO2013064681A1 N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use |
| 05/10/2013 | WO2013064519A1 Pesticidal compounds |
| 05/10/2013 | WO2013064461A2 Compounds with nematicidal activity |
| 05/10/2013 | WO2013006308A3 Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders |
| 05/10/2013 | WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors |
| 05/10/2013 | WO2012087174A3 Crystalline forms and processes for their preparation |
| 05/10/2013 | CA2854471A1 Pak inhibitors for the treatment of cell proliferative disorders |
| 05/10/2013 | CA2853967A1 8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity |
| 05/10/2013 | CA2853723A1 N-(pyrid-4-yl)amides and n-(pyrimidin-4-yl)amides and their pharmaceutical and cosmetic use |
| 05/10/2013 | CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine |
| 05/09/2013 | US20130116431 Novel HSP90 Inhibitor |
| 05/09/2013 | US20130116430 Novel nicotinamide derivative or salt thereof |
| 05/09/2013 | US20130116296 Pyrazole compound |
| 05/09/2013 | US20130116264 Novel Hetaryl (thio)carboxamide Compounds for Controlling Invertebrate Pests |
| 05/09/2013 | US20130116258 Androgen receptor modulators and uses thereof |
| 05/09/2013 | US20130116253 Novel HSP90 Inhibitor |
| 05/09/2013 | US20130116252 Novel HSP90 Inhibitor |
| 05/09/2013 | US20130116251 Novel HSP90 Inhibitor |
| 05/09/2013 | US20130116247 IRE-1alpha INHIBITORS |
| 05/09/2013 | US20130116240 Indole compounds and pharmaceutical use thereof |
| 05/09/2013 | US20130116238 Modulators of atp-binding cassette transporters |
| 05/09/2013 | US20130116232 Estrogen receptor modulators and uses thereof |
| 05/09/2013 | US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 05/09/2013 | US20130115194 Hepatitis c virus inhibitors |
| 05/09/2013 | US20130115193 Hepatitis C Virus Inhibitors |
| 05/09/2013 | US20130113367 Heterocyclic compound and organic light-emitting device including the same |
| 05/09/2013 | US20130112954 Dibenzo[f,h]Quinoxaline Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device |
| 05/08/2013 | EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2588474A2 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
| 05/08/2013 | EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588467A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588465A1 Sgc stimulators |
| 05/08/2013 | EP2588464A1 Benzofuran derivatives for the treatment of hepatits c |
| 05/08/2013 | EP2588458A1 Novel tetrahydroquinoline derivatives |
| 05/08/2013 | EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| 05/08/2013 | EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/08/2013 | EP2588104A1 Isoindolone m1 receptor positive allosteric modulators |
| 05/08/2013 | CN103097378A Novel method for producing 4-aminobut-2-enolides starting from 4-alkoxyfuran-2(5H)-on or 4-arylalkoxyfuran-2-(5H)-on |
| 05/08/2013 | CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2 |
| 05/08/2013 | CN103097373A Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/08/2013 | CN103097370A Benzofuran derivatives for the treatment of hepatits c |